Permanent Conduction System Pacing vs Native Conduction in Wide QRS with Intermittent Bradycardia
Official title: Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction
Run by Spanish Society of Cardiology · NCT07585799 · Data updated 2026-11-12
This study tests whether conduction system pacing can better preserve heart function than native conduction in adults with wide QRS and intermittent bradycardia who need a pacemaker.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Spanish Society of Cardiology Academic / other |
| Locations | 3 sites (Granada, Andalusia and 2 other locations) |
| Status | Recruiting |
| Started | July 29, 2025 |
| Main results expected | January 15, 2028 |
| Study ends | January 15, 2029 |
| Registry record updated | May 15, 2026 |
| Trial ID | NCT07585799 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with bradycardia requiring a pacemaker, wide QRS (≥150 ms or ≥130 ms with long PR), predominantly intact AV conduction, and LVEF ≥50%.
✕Probably not a fit
Patients with significant LV dysfunction, persistent AV conduction issues, or conditions making CSP unsuitable may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The multicenter trial is randomized and cross-over, enrolling adults with a pacemaker indication, wide QRS, and predominantly intact AV conduction. It compares conduction system pacing vs native conduction over 12 months, focusing on left ventricular ejection fraction and strain to measure remodeling and dyssynchrony. Primary outcome is the proportion with a ≥10% drop in LVEF or ≥15% drop in GLS at 12 months. Secondary outcomes include functional status, exercise capacity, quality of life, hospitalizations, mortality, arrhythmias, device longevity, and safety. The study uses CSP modalities (LBBP and LVSP) and analyzes subgroups by pacing indication and final CSP modality.
Why it matters
Potential benefit: If CSP shows superior preservation of heart function, patients could experience better overall cardiac performance and quality of life.
How similar studies have gone: Previous work suggests physiologic pacing can improve synchronization, but results vary by modality and population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age \> 18 years * Any indication for cardiac pacing with an expected VP burden ≤ 10% after 1- month run-in period * Baseline wide QRS (≥150 ms) with normal PR or QRS ≥ 130 ms + PR≥230 ms * LVEF≥50% * Confirmed CSP criteria * Signed and dated informed consent Exclusion Criteria: * Pregnant woman * Permanent or long-lasting atrial fibrillation * Previous PM/ICD * Unstable angina, acute Myocardial Infarction (MI), Coronary Artery Bypass Graft (CABG), Percutaneous Coronary Angioplasty (PCI), surgical valve repair or replacement within 90 days prior enrollment * Moderate-severe valvular heart disease (unrepaired) * Already included in another clinical study that could confound the results of the present study * Infiltrative disease or any other genetically or acquired primary myocardial disease * Life expectancy \< 2 years * LVEF \<50%
Where it's running
-
Hospital Universitario Virgen de las Nieves
Granada, Andalusia, Spain Recruiting -
Hospital Clínico Universitario Lozano Blesa
Zaragoza, Aragon, Spain Recruiting -
Hospital Universitari i Politècnic La Fe
Valencia, Valencia, Spain Recruiting
Study contacts
- Study coordinator: Óscar Cano, MD, PhD
- Email: cano_osc@gva.es
- Phone: +34 961244000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SPIKE FLOW endocardial pacing lead safety and performance study
This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.
-
Factors Linked to Slow Heart Rate After Pulsed Field Ablation for Atrial Fibrillation
This study looks for factors that might cause bradycardia during the hospital stay after AF ablation using pulsed field technology.
-
Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing
This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.
-
Conduction System Pacing Display Research During LBBAP Implant
Researchers are testing a CSP Display System during left bundle branch area pacing pacemaker implant to see if it accurately shows heart signals compared with a standard ECG.
-
Focal Cryoablation vs. Radiofrequency Cardioneuroablation for Bradyarrhythmias
This study tests whether focal cryoablation can treat vagally driven slow heart rhythms as well as traditional radiofrequency ablation in adults with bradycardia or related syncope.
-
Personalized pacing rate to see if higher lower rate helps heart and brain flow
In hypertensive patients with bradycardia who need a dual-chamber pacemaker, the study tests whether setting a higher, personalized pacing rate improves heart function and brain blood flow compared with the standard 60 bpm.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.